Catalyst Pharmaceuticals Inc (CPRX)

Operating profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Operating income US$ in thousands 195,124 86,812 101,838 52,385 41,303
Revenue US$ in thousands 491,734 398,204 214,203 140,833 119,073
Operating profit margin 39.68% 21.80% 47.54% 37.20% 34.69%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $195,124K ÷ $491,734K
= 39.68%

Catalyst Pharmaceuticals Inc has demonstrated a fluctuating trend in its operating profit margin over the past five years. The operating profit margin increased steadily from 34.69% as of December 31, 2020, to 47.54% as of December 31, 2022, indicating efficient cost management and potentially improving revenue generation during this period.

However, there was a significant decline in the operating profit margin to 21.80% as of December 31, 2023, suggesting potential challenges or increased costs impacting profitability. Despite this decrease, Catalyst Pharmaceuticals Inc managed to recover and improve its operating profit margin to 39.68% as of December 31, 2024.

Overall, the company's operating profit margin experienced fluctuations over the analyzed period, indicating the need for ongoing monitoring and potential strategic adjustments to maintain and enhance profitability in the future.